Technology
Health
Medical

CorMedix

$4.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.26 (-5.94%) Today
$0.00 (0.00%) As of 7:21 AM EDT after-hours

Why Robinhood?

You can buy or sell CorMedix and other stocks, options, ETFs, and crypto commission-free!

About CRMD

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Read More It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.

CEO
Mohammed Khoso Baluch
Employees
30
Headquarters
Berkeley Heights, New Jersey
Founded
2006
Market Cap
125.95M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
723.18K
High Today
$4.40
Low Today
$3.94
Open Price
$4.40
Volume
906.09K
52 Week High
$8.77
52 Week Low
$2.16

Collections

Technology
Health
Medical
Pharmaceutical
US
North America

CRMD News

BenzingaAug 7

Cormedix's Earnings: A Preview

Cormedix (AMEX: CRMD) unveils its next round of earnings this Monday, August 10. Here is Benzinga's everything-that-matters guide for the earnings announcement.

CRMD Earnings

-$0.28
-$0.18
-$0.08
$0.02
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
-$0.14 per share
Actual
Available Aug 10, After Hours
Preview Earnings Call

You May Also Like

CNF
WMGI
CGROU
OZK
SVXY
KGFHY
GAINL
WRB-B
ABBV
RPAI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CRMD

Market Price$4.12
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CorMedix stock and options commission-free.
LearnBlogCareersHelpLog InSign Up